ReviewAnnals of hematology2020

The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion.

Sophie Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.